Drug-induced endovesiculation of erythrocytes is modulated by the dynamics in the cytoskeleton/membrane interaction

被引:7
|
作者
Oberwagner, Walter [1 ]
Sauer, Thomas [1 ]
Hermann, Andreas [2 ]
Prohaska, Rainer [1 ]
Muellner, Ernst W. [1 ]
Salzer, Ulrich [1 ]
机构
[1] Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, Vienna, Austria
[2] Tech Univ Dresden, Dept Neurol, German Ctr Neurodegenerat Dis DZNE, Dresden, Germany
关键词
RED-BLOOD-CELLS; CHOREA-ACANTHOCYTOSIS; MEMBRANE FLUCTUATIONS; ACTIN; SHAPE; PROTEIN; VESICULATION; INHIBITION; MECHANICS; VANADATE;
D O I
10.1016/j.bcmd.2017.03.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent studies on erythrocyte membrane fluctuations revealed that the erythrocyte cytoskeleton actively modulates its membrane association thereby regulating crucial membrane properties. Cationic amphiphilic drugs like chlorpromazine are known to induce a cup-like cell shape and vesicle formation into the cell interior, effectors of this process, however, are largely unknown. Using flow cytometry, this study explored conditions that influence endovesiculation induced by chlorpromazine. We found that inhibitors of membrane fluctuations, like ATP depletion, vanadate or fluoride, also inhibited endovesiculation whereas activation of PKC, known to decrease cytoskeleton association and increase membrane fluctuations, also enhanced endovesicle formation. This indicates that endovesicle formation and membrane fluctuations are modulated by the same cytoskeleton-regulated membrane properties. Further, acanthocytic erythrocytes of chorea acanthocytosis (ChAc) patients that lack the VPS13A/chorein protein - likely a crucial organizer at the erythrocyte cytoskeleton/membrane interface showed a strong decrease in chlorpromazine-induced endovesiculation. The responses of ChAc erythrocytes to effectors of endovesiculation were similar to that of control erythrocytes, yet at drastically reduced levels. This suggests a more rigid and less dynamic interaction at the membrane-cytoskeleton interphase of ChAc erythrocytes. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:15 / 22
页数:8
相关论文
共 50 条
  • [21] Drug-induced cardiomyopathy revealed from mitochondrial dynamics
    Muraoka, Mikio
    Yanagisawa, Teruyuki
    Satou, Takeya
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 131P - 131P
  • [22] Drug-induced symmetry effects on ventricular repolarization dynamics
    Daniel Cruces, Pablo
    Toscano, Alejandra
    Alvarado Rodriguez, Francisco Javier
    Romo-Vazquez, Rebeca
    David Arini, Pedro
    BIOMEDICAL SIGNAL PROCESSING AND CONTROL, 2023, 81
  • [23] RELATIONSHIP BETWEEN DRUG-INDUCED AND PHOSPHOLIPASE-INDUCED SHAPE CHANGES OF HUMAN-ERYTHROCYTES
    TAMURA, A
    SATO, T
    FUJII, T
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1984, 32 (05) : 1904 - 1911
  • [24] Nanopore-related cellular death through cytoskeleton depolymerization by drug-induced ROS
    Zhang, Yan
    Xu, Renfeng
    Wu, Jingjing
    Zhang, Zhenghong
    Wang, Yuhuang
    Yang, Hongqin
    Zhang, Sheng
    TALANTA, 2024, 268
  • [25] DRUG-BINDING TO HUMAN ERYTHROCYTES IN THE PROCESS OF IONIC DRUG-INDUCED HEMOLYSIS - FLOW MICROCALORIMETRIC APPROACHES
    AKI, H
    YAMAMOTO, M
    BIOCHEMICAL PHARMACOLOGY, 1991, 41 (01) : 133 - 138
  • [26] Idiosyncratic Drug-Induced Liver Injury: Is Drug-Cytokine Interaction the Linchpin?
    Roth, Robert A.
    Maiuri, Ashley R.
    Ganey, Patricia E.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 360 (02): : 368 - 377
  • [28] Drug-induced transmembrane lipid scrambling in erythrocytes and in liposomes requires the presence of polyanionic phospholipids
    Moreau, C
    Sulpice, JC
    Devaux, PF
    Zachowski, A
    MOLECULAR MEMBRANE BIOLOGY, 1997, 14 (01) : 5 - 12
  • [29] STUDIES ON ERYTHROCYTES IN CASES WITH PAST HISTORY OF FAVISM AND DRUG-INDUCED ACUTE HEMOLYTIC ANEMIA
    SZEINBERG, A
    SHEBA, C
    HIRSHORN, N
    BODONYI, E
    BLOOD, 1957, 12 (07) : 603 - 613
  • [30] EFFECT OF DRUGS ON HUMAN ERYTHROCYTES .2. POSSIBLE MECHANISM OF DRUG-INDUCED HEMOLYSIS
    OGISO, T
    KUROBE, M
    MASUDA, H
    KATO, Y
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1977, 25 (05) : 1078 - 1088